AAPLOG Action urges Congress to pass Hawley's bill withdrawing mifepristone's approval for abortion

AAPLOG ActionAdvocacy arm of the American Association of Pro-Life Obstetricians and Gynecologists, in a statement of support released through Senator Hawley's office

Defended or excused

AAPLOG Action, the advocacy arm of the American Association of Pro-Life Obstetricians and Gynecologists, said in a statement of support released through Senator Hawley's office that it supports the bill and urges Congress to pass it. The statement calls removing mifepristone's approval for induced abortion a great step toward the evidence-based healthcare it says it is committed to providing.

“AAPLOG Action, the advocacy arm of the American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG), supports the Safeguarding Women from Chemical Abortion Act, and thanks Senator Hawley for introducing this important legislation. The Safeguarding Women from Chemical Abortion Act would withdraw approval of mifepristone for use in induced abortion. When the FDA illegally fast-tracked its original approval they recognized that this drug had significant risks – even then. In recent years, important safeguards – including in-person dispensing of mifepristone and follow-up care – have been removed, making mifepristone available through the mail and without medical oversight. This has significantly increased the risks not only our preborn patient, but also our maternal patient. Women deserve better. We are committed to providing excellent, evidence-based healthcare to both our patients, and removing mifepristone’s approval for induced abortion is a great step towards that goal. AAPLOG Action urges Congress to pass the Safeguarding Women from Chemical Abortion Act.”

Official statement

Read the official statement (opens in a new tab)Statements of Support for the Safeguarding Women from Chemical Abortion Act · Josh HawleyPage 1, statement attributed to Marjorie Dannenfelser, President of SBA Pro-Life America.

Official statement

Read the official statement (opens in a new tab)Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.

Case updates

Tracking Josh Hawley's push to ban the abortion pill

Get an email if the mifepristone bill moves in committee or gains cosponsors, or if candidates sign or reject Hawley's Declaration for Life pledge.

Important updates only. Free. Confirm your email to start. Unsubscribe anytime. How we handle your email.

Conceptual image of generic white tablets in a blister pack beneath a shadow resembling the U.S. Capitol.
Credit: The Dispute Index / AI-generated illustration

Where this statement fits

Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

On March 11, 2026, Senator Josh Hawley introduced the Safeguarding Women from Chemical Abortion Act, which would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and let women who say chemical abortion harmed them sue its manufacturers. Mifepristone has been approved in the United States since 2000 and is used in a large majority of American abortions. Hawley argues a national ban is the only remedy because the drug can be mailed into states whose own laws restrict abortion. The bill drew seven Republican cosponsors but has not moved out of the Senate Health, Education, Labor and Pensions Committee. On September 16, 2026, Hawley unveiled a four-page "Declaration for Life" and began asking officeholders and candidates to sign it as a commitment to ban the drug. The dispute is over whether Congress should enact that ban.

Read the full case

Source and context

Official statement

Statements of Support for the Safeguarding Women from Chemical Abortion Act (opens in a new tab) · Josh HawleyPage 1, statement attributed to Marjorie Dannenfelser, President of SBA Pro-Life America.

About this source

Two-page compilation of statements of support for the bill from eight anti-abortion organizations, released by Senator Hawley's office and linked from his March 11, 2026 announcement of the bill.

Archived copy (opens in a new tab)

Official statement

Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders (opens in a new tab) · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.

About this source

Hawley's own announcement of the bill, issued alongside a Capitol Hill press conference with anti-abortion movement leaders. It states the bill's three operative provisions and carries the quotation on which his safety claim rests.

Archived copy (opens in a new tab)

Before the quotation

On March 11, 2026, Senator Josh Hawley introduced the Safeguarding Women from Chemical Abortion Act, which would withdraw the FDA's approval of mifepristone for abortion. His release listed the American Association of Pro-Life OBGYNs Action among the organizations supporting the bill and pointed readers to their statements.

After the quotation

The same two-page document carries statements from seven other groups, among them Susan B. Anthony Pro-Life America, Students for Life of America and Alliance Defending Freedom.

How this statement is classified

Defended or excused

The label describes this statement's response within the context above.

Why this label?

The reference point is Hawley's proposal that Congress ban mifepristone by withdrawing its federal approval. AAPLOG Action said it supports the bill, thanked Hawley, and urged Congress to pass it. That is direct support for the ban, so we labeled it Defended or excused.

Recorded on
Published here
People and groups discussed
Josh Hawley

More from this case

Read the full case

Share or embed this statement

Quote card: AAPLOG Action, AAPLOG Action urges Congress to pass Hawley's bill withdrawing mifepristone's approval for abortionDownload image (PNG)

The embed keeps its attribution link to The Dispute Index. Credit the image to The Dispute Index and link to the statement page.

Cite this record

Publisher
The Dispute Index
Title
AAPLOG Action urges Congress to pass Hawley's bill withdrawing mifepristone's approval for abortion
First published
Last updated
Permalink
https://disputeindex.com/events/3486-aaplog-action-the-advocacy-arm-of-the-american

Last updated marks the most recent saved version of this published statement.

The Dispute Index. "AAPLOG Action urges Congress to pass Hawley's bill withdrawing mifepristone's approval for abortion". First published: 2026-09-30. Last updated: 2026-09-30. https://disputeindex.com/events/3486-aaplog-action-the-advocacy-arm-of-the-american